Drug
NW-301D clinical trials
Also written NW-301D.
- studies test it
- 3
- open now
- 2
- in phase 3
- 0
- first study started
- 2024
Keep track of what changes. Save the NW-301D studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses NW-301D is read from its arms, and is right about nine times in ten.
Testing it · 3
- T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid TumorRecruitingPhase 1Ting DengNCT06484790Written as NW-301D
- T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid TumorRecruitingPhase 1Tao ZhangNCT06484556Written as NW-301D
- T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid TumorActive, not recruitingPhase 1TingBo LiangNCT06478251Written as NW-301D